Article Figures & Data
Tables
- Table 1.
Postulated mechanisms of cardiorenal protection of glucagon-like peptide 1 receptor agonists
Kidney Cardiac Systemic Oxygenation Decreased oxygen consumption
Improved ATP availability
Lipids Decreased LDL
Decreased triglycerides
Blood glucose concentrations Decreased blood glucose
Improved insulin resistance
GFR and urine albumin excretion Improved GFR
Decreased urine albumin-creatinine ratio
Metabolic profile Decreased weight
Inflammatory response Decreased inflammatory cytokines
Sodium and fluid balance Decreased sodium retention
Decreased BP
BP Decreased BP
Coagulation profile Improved coagulation profile